P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
4,874.55
52.95 (1.1%)
BSENSE

Mar 20

BSE+NSE Vol: 30.25 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,037.52
1,574.40
-536.88
-34.10%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,037.52
1,574.40
-536.88
-34.10%
Raw Material Cost
222.14
722.14
-500.00
-69.24%
Purchase of Finished goods
48.27
63.51
-15.24
-24.00%
(Increase) / Decrease In Stocks
1.80
10.92
-9.12
-83.52%
Employee Cost
171.70
285.67
-113.97
-39.90%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
272.54
281.52
-8.98
-3.19%
Total Expenditure (Excl Depreciation)
716.45
1,363.75
-647.30
-47.46%
Operating Profit (PBDIT) excl Other Income
321.07
210.65
110.42
52.42%
Other Income
13.34
119.09
-105.75
-88.80%
Operating Profit (PBDIT)
334.41
329.74
4.67
1.42%
Interest
0.34
87.11
-86.77
-99.61%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
334.07
242.63
91.44
37.69%
Depreciation
17.42
66.05
-48.63
-73.63%
Profit Before Tax
316.65
176.59
140.06
79.31%
Tax
84.34
9.31
75.03
805.91%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
232.31
167.29
65.02
38.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
232.31
167.29
65.02
38.87%
Equity Capital
16.60
92.17
-75.57
-81.99%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
30.95%
13.38%
0.00
17.57%
Gross Profit Margin
32.20%
15.41%
0.00
16.79%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,037.52 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 232.31 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 321.07 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

Nine Monthly - Interest
Interest 0.34 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.95%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024